Upload
mikee-melad
View
224
Download
0
Embed Size (px)
Citation preview
7/27/2019 HECO U1 - Pharm Business Firm1-2
1/38
THE
PHARMACEUTICALBUSINESS
7/27/2019 HECO U1 - Pharm Business Firm1-2
2/38
TYPES OF BUSINESS FIRMS
2. Financial Business
3. Information Business
4. Manufacturers
5. Real Estate Business
1. Agriculture and Mining business
6. Retailers and Distributors
7. Service Businesses8. Transportation Business
9. Utilities
7/27/2019 HECO U1 - Pharm Business Firm1-2
3/38
FORMS OF BUSINESS ORGANIZATIONS
Business Firms are organized into 3 distinct
groups
1. The major forms
2. The minor forms
3. The modified corporate form
7/27/2019 HECO U1 - Pharm Business Firm1-2
4/38
THE MAJOR FORMS OF BUSINESSORGANIZATION
2. Partnership
3. Corporation
1.Sole Proprietorship
7/27/2019 HECO U1 - Pharm Business Firm1-2
5/38
KINDS OF PARTNERSHIP
1. General Partner
2. Limited Partner
3. Universal Partner
4. Capitalist Partner
5. Industrial Partner
6. Silent Partner
7. Secret Partner
8. Dormant Partner
9. Nominal Partner
7/27/2019 HECO U1 - Pharm Business Firm1-2
6/38
2 TYPES OF CORPORATION
1. Public Corporation
2. Private Corporation
A. Closed Corporation
B. Open Corporation
7/27/2019 HECO U1 - Pharm Business Firm1-2
7/38
7/27/2019 HECO U1 - Pharm Business Firm1-2
8/38
THE MODIFIED CORPORATE FORM OFBUSINESS ORGANIZATION
1. Cooperatives
a. Credit union d. Consumers cooperative
b. Producers cooperative e. Service cooperativec. Marketing cooperative
2. Mutual companies
a. Mutual savings banks
b. Mutual insurance company
7/27/2019 HECO U1 - Pharm Business Firm1-2
9/38
THE PHARMACEUTICAL HEALTH CAREINDUSTRY
7/27/2019 HECO U1 - Pharm Business Firm1-2
10/38
THE WORLD DRUG MARKET
Key World Markets Drug Sales in US$ Billion
1. United states 189.81
2. Canada 9.41
3. United Kingdom 14.584. European Markets 82.42
5. Japan 55.69
6. France 20.17
7. Germany 23.99
8. Mexico 6.28
7/27/2019 HECO U1 - Pharm Business Firm1-2
11/38
DISTRIBUTORS/COMPANIES DOING OWN DISTRIBUTION
TRADERS OR SUB-DISTRIBUTORS
DRUGSTORES 85.6% HOSPITAL 11.0% OTHER RETAIL 3.4%
INDEPENDENT27.9%
CHAIN57.7%
PRIVATE8.1%
GOVERNMENT2.9%
INDUSTRIALCLINICS w/o
BED3.0%
GOVERNMENTAGENCIES
0.4%
CLINICS W/BEDS
INDUSTRIALHOSP.
C O N S U M E R
DISTRIBUTION CHANNELS ACCORDING TO SALES
7/27/2019 HECO U1 - Pharm Business Firm1-2
12/38
MARKET DRIVERS
PHILIPPINE PHARMACEUTICAL MARKET
Independent Drugstore
Health Care Centers
MARKET DRIVERS IN THE HOSPITAL SECTOR1. Private Hospitals
2. PhilHealth Insurance
Program3. Public Hospitals
4. Clinical Pharmacy
Practice
5. Health MaintenanceOrganizations
Chain Drugstores
7/27/2019 HECO U1 - Pharm Business Firm1-2
13/38
SOURCES OF FUNDS FOR PHARMACEUTICALPRODUCTS
Total 536 per person, 10% of National
health expenditures
Out-of-pocket 32%Private insurance 46%
Medicare/PhilHealth 17%
Other Insurance 2%
Other Public programs 3%
7/27/2019 HECO U1 - Pharm Business Firm1-2
14/38
PharmacyBenefit
Manager5-15%
Retail Pharmacy15-25%
Brand name
Pharmaceutical
Companies
70-80%
Wholesale2-3%
Generic Manufacturers 6%
PATIENTS
FLOW OF FUNDS IN THE PHARMACEUTICAL MARKET
7/27/2019 HECO U1 - Pharm Business Firm1-2
15/38
Out-Patients
DRUGSTORES
Rx generated fromResidents MDs/
Consultants
Buys Rx
Out-Patient Department(OPD) Hospitals
FLOW OF RX IN THEHOSPITAL OPD
7/27/2019 HECO U1 - Pharm Business Firm1-2
16/38
In-Patient Department(IPD) Hospitals
In-Patient(Confined in Hospitals)
Hospital Pharmacy
Rx generated fromResidents MDs/
Consultants
Rx In Patients ChartServed by nurses
FLOW OF RX INHOSPITAL IPD
7/27/2019 HECO U1 - Pharm Business Firm1-2
17/38
Out-Patient In-Patient
Emergency Rooms(ER)
HospitalsDrugstores
Emergency Rooms(ER)
Hospitals
Emergency Rooms (ER)HOSPITALS
FLOW OF RX IN HOSPITAL ERS
Rx bought/served
Rx served
Rx generated from, Residents MDs/Consultants
7/27/2019 HECO U1 - Pharm Business Firm1-2
18/38
Channel 1 Consists of a drug
manufacturer selling directly
to the DOH or government
health units and hospitalswho will in turn make the
medicines available to the
end-users practically for free.
A local drug trader may serve
as the intermediary level in
behalf of the drug
manufacturer in transacting
business with DOH.
Drug Manufacturer
Department of HealthGovt. Health Units
Govt. Hospitals
End Users
LocalDrug
Trader
DIFFERENT FLOWS OFPHARMACEUTICALS
7/27/2019 HECO U1 - Pharm Business Firm1-2
19/38
Channel 2 Contains 2 middlemen level.
A sales representative of a
drug manufacturer selling to
dispensing physicians who inturn sells the medicines to
the patients (end-users)
charging the latter
consultation fees andmedicines given
Drug Manufacturer
Sales reps
DispensingPhysicians
END USERS
7/27/2019 HECO U1 - Pharm Business Firm1-2
20/38
Channel 3 Contains only 1
middlemen level,
either an independentdistributor or retailer,
who in turn sells the
drug products to end-
user
Drug Manufacturer
Independent
Distributors
END USERS
Retailers
7/27/2019 HECO U1 - Pharm Business Firm1-2
21/38
Channel 4 Contains 2 middlemen
level, namely the
wholesaler and retailer
drugstore outlets who in
turn sells to the end-
users. In some
companies, 3 middlemen
level when its theirsalesman that facilitates
the transactions.
Drug Manufacturer/
Distributors
Wholesaler
Retailer
END USERS
7/27/2019 HECO U1 - Pharm Business Firm1-2
22/38
Channel 5 Contains 3 middlemen
level, reflecting
jobbers who ells to thesmaller retailers
generally are not
served by the large
wholesaler drugstores
Drug Manufacturers/
Distributions
Wholesaler
End Users
JOBBERS
Retailers
7/27/2019 HECO U1 - Pharm Business Firm1-2
23/38
Drug Manufacturer
IndependentDistributors
CompanyWarehouse
Branch operations Franchise Operations
Mercury Drug Corp.
Traditional Outlets Traditional Outlets
Non-Traditional Non-TraditionalEnd Users
FLOWCHARTDISTRIBUTION
7/27/2019 HECO U1 - Pharm Business Firm1-2
24/38
UNILABManufacturer
GMAWarehouse
ProvincialWarehouse
Drugstores Hospitals
Industrial Clinics Non-traditional Outlets Dispensing Physicians Department of Health
END USERS
United LabDistribution Flow
Chart
7/27/2019 HECO U1 - Pharm Business Firm1-2
25/38
Drug Manufacturer
National Distributor
PrivateInstitution
DispensingPhysicians
GovernmentDistributors
Wholesale/Retailer(drugstores)
GovernmentAgencies
Pure Retailers(drugstores)
END USERS
PharmaceuticalCompany DistributionFlow Chart
7/27/2019 HECO U1 - Pharm Business Firm1-2
26/38
PHASES OF THE BUSINESS
CYCLE1. The prosperity phase
2. The crisis (or contraction or recession) phase
3. The depression phase
4. The recovery (or expansion) phase
7/27/2019 HECO U1 - Pharm Business Firm1-2
27/38
CHARACTERISTICS OF PROSPERITY PHASE
High prices and great
business activity
Large profits for business
firms Production is at full
capacity
Increasing demand formany commodities
Increasing demand for
labor
Increasing volume of sales
Increasing volume of credit
extensions by lenders
Large demand for credit
Rising interest rates
7/27/2019 HECO U1 - Pharm Business Firm1-2
28/38
Great
BusinessActivity
BusinessFirms
GreatDemand
Raw MaterialsAnd other
Commodities
LABOR LANDCapital
Resulting to
Resulting to
Higher outputs
Higher sales
Higher profits
Higher Wages
Higher Rent
Higher Interest Rate
Higher Prices ofMaterials and Supplies
THE PROSPERITY PHASE
7/27/2019 HECO U1 - Pharm Business Firm1-2
29/38
CRISIS OR RECESSION PHASE
The demand for goodsdecreases
The margin of profitsgradually shrinks
The volume of salesdecreases
Trading slows down
The production of goods isreduced
The demand for labor,
capital, and land decreases
Prices go down
The ability of business firmsto meet their financial
obligations is impaired
Unemployment begins to
bother labor No further extensions of
credit or renewals of old
loans are made by banks
7/27/2019 HECO U1 - Pharm Business Firm1-2
30/38
Reduced
BusinessActivity
BusinessFirms
ReducedDemand
LABORRaw Materials
And otherCommodities
Capital LAND
THE CRISIS OR RECESSIONPHASE
Resulting to
Resulting todecreasing outputs sales,
and profits
decreasing wages, rent,interest rates, prices ofraw materials andsupplies
7/27/2019 HECO U1 - Pharm Business Firm1-2
31/38
DEPRESSION PHASE
Many business haveceased operations
Profits are minimal, if it isstill possible to make some
Banks have plenty of idlefunds
Banks are gradually
reduce interest rates
Credits starts to become
available
Unemployment is at its
highest level Many unemployed persons
are willing to work at lower
wages
The prices of raw materials
and supplies are low
7/27/2019 HECO U1 - Pharm Business Firm1-2
32/38
Greatly Reduced
BusinessActivity
Reduced #Of Firms
Still Operating
LABORRaw Materials
And otherCommodities
Capital LAND
Resulting to
Resulting to
THE DEPRESSION PHASE
Very LowDemand
Minimal output,sales, and profit
low wages, rent,interest rates
low prices of rawmaterials and
supplies
7/27/2019 HECO U1 - Pharm Business Firm1-2
33/38
RECOVERY PHASE
As the supply ofcommodities in the market
gets exhausted, demand
for these begin to be felt
Optimism amongbusinessmen slowly
develops, prodding them to
increase business activity
The demand for labor
increases, resulting to a
decrease in unemployment
The purchasing power ofthe people rises
The low rates of interest willattract business borrowings
Prices slowly rise There is an increase in
production output
Idle plans are used and
plans for construction ofnew ones are considered
7/27/2019 HECO U1 - Pharm Business Firm1-2
34/38
Increasing
BusinessActivity
BusinessFirms
IncreasingDemand
LABORRaw Materials
And otherCommodities
Capital LAND
Resulting to
Resulting to
THE RECOVERY PHASE
increased
outputs, sales,and profits
increasedwages, rent,interest rates,prices of raw
materials andsupplies
7/27/2019 HECO U1 - Pharm Business Firm1-2
35/38
CONTROL OF BUSINESS CYCLES
1. The stabilization of business2. Control of credit
3. Control of public works
4. Business forecasting
5. Monetary readjustment
6. Payment of high wages
7. Economic planning
7/27/2019 HECO U1 - Pharm Business Firm1-2
36/38
TYPES OF INFLATION
1. Cost-push inflation is one characterized by continualdecreased in the aggregate supply, resulting to increase
in the cost of production
2. Demand-pull inflation is one caused by increases inaggregate demand
3. Inertial inflationis that steady inflation that occurswhen inflation is expected to persist and the ongoing rate
of inflation is built into contracts and peoples
expectations
7/27/2019 HECO U1 - Pharm Business Firm1-2
37/38
LOSERS AND GAINERS IN INFLATION
LOSERS
1. Fixed income earners
2. Pensioners
3. Creditors
GAINERS
1. Businessmen
2. Speculators
3. Debtors
CONTROLLING INFLATION
1. Monetary Policy
2. Fiscal Policy
7/27/2019 HECO U1 - Pharm Business Firm1-2
38/38
FACTORS ATTRIBUTED TO SALES DECLINE
1. Rapid technological advances
2. Changing consumer preferences
for taste, flavors and colors
3. Adherence to safety and
efficacy
4. Price consciousness due toinflation and deteriorating
purchasing power